The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
The DNase-B Antibody test contains 1 test with 1 biomarker.
Brief Description: The DNase-B Antibody test, commonly referred to as Anti-DNase B or simply DNase test, is a laboratory test that measures the level of DNase-B antibodies in the bloodstream. Antibodies are proteins produced by the immune system in response to harmful entities like bacteria or viruses. DNase-B antibodies, in particular, are generated in response to a protein produced by the group A Streptococcus bacteria.
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: No preparation required
A DNase-B Antibody test is often ordered when a patient presents with symptoms suggestive of a post-streptococcal complication or when a patient has had a recent streptococcal infection but has tested negative in rapid strep tests or throat cultures. The reasons to order this test include:
Suspected Post-Streptococcal Conditions: Certain conditions can develop after an infection with group A Streptococcus. These conditions, such as rheumatic fever or post-streptococcal glomerulonephritis, can have serious implications for a patient's health.
Previous Infections: In cases where an individual might have had a streptococcal infection that was either untreated or inadequately treated.
Negative Rapid Tests: When a patient has symptoms of a streptococcal infection but other rapid tests or cultures are negative.
The DNase-B Antibody test checks for the presence and levels of DNase-B antibodies in the blood. A significant increase in these antibodies indicates a recent infection with group A Streptococcus.
When a DNase-B Antibody test is ordered, it's often part of a broader evaluation of streptococcal infections and their complications. Here are some tests commonly ordered alongside it:
Antistreptolysin O (ASO) Titer:
Complete Blood Count (CBC) with Differential:
Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP):
These tests, when ordered alongside a DNase-B Antibody test, provide a comprehensive evaluation of past or recent Group A Streptococcus infection and its potential complications. They are crucial for diagnosing streptococcal infections, assessing the risk of associated conditions like rheumatic fever and glomerulonephritis, and guiding treatment decisions. The specific combination of tests will depend on the individual’s symptoms, clinical presentation, and medical history.
The DNase-B Antibody test is particularly useful for diagnosing:
Rheumatic Fever: A serious condition that can affect the heart, skin, joints, and brain.
Post-Streptococcal Glomerulonephritis: A kidney disorder that can arise after a streptococcal infection.
Healthcare providers use the results of the DNase-B Antibody test to:
Confirm a Recent Infection: Elevated levels of DNase-B antibodies can confirm a recent group A Streptococcus infection, even if the bacteria are no longer present.
Diagnose Post-Streptococcal Complications: The test helps in the diagnosis of conditions like rheumatic fever or glomerulonephritis, especially when combined with clinical findings and other lab tests.
Guide Treatment: Knowing that a condition is post-streptococcal in nature can guide therapeutic decisions, such as the initiation or continuation of antibiotics.
In conclusion, the DNase-B Antibody test is a vital diagnostic tool that helps healthcare providers confirm recent streptococcal infections and diagnose conditions that arise as complications of these infections.
What is the main objective of the DNase-B Antibody test?
The DNase-B Antibody test is utilized to detect the presence of antibodies against deoxyribonuclease B (DNase-B) in the blood. These antibodies are typically elevated in individuals with post-streptococcal complications such as rheumatic fever or glomerulonephritis following an infection with group A Streptococcus bacteria.
When is the DNase-B Antibody test typically ordered by physicians?
Physicians usually order the DNase-B Antibody test when they suspect that a patient may have developed a complication following a streptococcal infection. This is especially the case when symptoms like joint pain, swelling, and heart-related issues (common in rheumatic fever) or kidney problems (seen in glomerulonephritis) are present.
How are the results of the DNase-B Antibody test generally interpreted?
The interpretation of the DNase-B Antibody test results is based on the titers or concentration of DNase-B antibodies in the blood. Elevated levels suggest a recent or current streptococcal infection and may indicate complications like rheumatic fever or post-streptococcal glomerulonephritis. However, the test results should always be considered in conjunction with clinical symptoms and other diagnostic tests.
If there are abnormalities in the DNase-B Antibody test, what might be the next steps?
If elevated DNase-B antibody levels are detected, further evaluation might be necessary. This could include additional laboratory tests, imaging studies, or specialist referrals, especially if rheumatic fever or glomerulonephritis is suspected. Medical management might involve antibiotics to treat any lingering streptococcal infection, anti-inflammatory drugs, and monitoring or treatment for heart or kidney issues.
How is the DNase-B Antibody test different from the ASO (antistreptolysin O) titer test?
Both the DNase-B Antibody test and the ASO titer test are used to detect antibodies produced in response to a group A streptococcal infection. However, they target different antibodies. While the DNase-B test detects antibodies against the DNase-B enzyme produced by streptococcal bacteria, the ASO test detects antibodies against the streptolysin O enzyme. Often, these tests might be ordered together to provide a comprehensive view of the immune response to streptococcal infections.
Are there conditions or factors that might influence the results of the DNase-B Antibody test?
Yes, certain conditions or factors can affect the results of the DNase-B Antibody test. Recent or concurrent infections with other types of bacteria or viruses might produce cross-reacting antibodies that could influence the test. Chronic illnesses, immunodeficiency conditions, and certain medications that suppress the immune system might also affect antibody production and thus the test results.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.